fullscreen

eFinder

eFinder

Home › Article

From lockdown to the lab: Researcher develops 'decoy molecule' to slow down coronavirus

Phys · · 652 words · By Hilde Pracht
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about From lockdown to the lab: Researcher develops 'decoy molecule' to slow down coronavirus

Ph.D. candidate Koen Rijpkema developed a decoy molecule to inhibit a coronavirus enzyme during the pandemic. His research faced challenges including competition from another group and reliance on trial-and-error methods. The molecule is a research tool rather than a direct treatment.

Propaganda risk 0%
Claims checked 10
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left25%
Center50%
Right25%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

From lockdown to the lab: Researcher develops 'decoy molecule' to slow down coronavirus Lisa Lock scientific editor Robert Egan associate editor While the Netherlands was in lockdown because of the coronavirus, Ph.D.

Why it matters

candidate Koen Rijpkema began his research into the same virus.

Common ground

In the lab, he developed molecules that can inhibit an important viral enzyme.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

Ph.D. candidate Koen Rijpkema developed a decoy molecule to inhibit a coronavirus enzyme during the pandemic. His research faced challenges including competition from another group and reliance on trial-and-error methods. The molecule is a research tool rather than a direct treatment.

open_in_new Read the original article: https://phys.org/news/2026-04-lockdown-lab-decoy-molecule-coronavirus.html

analyticsAnalysis

0%
Propaganda Score
confidence: 95%
Low risk. This article shows minimal use of propaganda techniques.

fact_checkClaims Checked

eFinder analyzed this article and checked 10 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 4
info Single Source 3
help Insufficient Evidence 2
verified Verified By Reference 1
info
Claim 1: “Rijpkema used trial and error to develop the synthetic molecule.”
SINGLE SOURCE
Web results mention optimization techniques and protein engineering but do not explicitly state trial-and-error methods. The claim requires direct confirmation of iterative experimentation, which is not present in the evidence.
travel_explore
web search NEUTRAL — Starting point is a sequential approximate optimization approach, where response-surface techniques are employed to build multipoint linear approximations of objective function and constraints in ...
https://www.researchgate.net/profile/J-Rijpkema
travel_explore
web search NEUTRAL — Dive into the research topics where J.J.M. (Koo) Rijpkema is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
https://research.tue.nl/en/persons/jjm-koo-rijpkema/
travel_explore
web search NEUTRAL — 1 day ago · The target protein FeZ12 was then eluted using elution buffer (50 mM Tris-HCl, 500 mM NaCl, 350 mM imidazole, pH 7.4). The target protein was dialyzed twice at 4 °C in dialysis buffer (20 …
https://www.sciencedirect.com/science/article/pii/S096399692…
info
Claim 2: “Computer models were ineffective for designing the molecule due to limited knowledge about Mac1.”
SINGLE SOURCE
All web results pertain to technical errors in machine learning model loading (e.g., LM Studio issues), which are unrelated to Mac1 research methodology. No evidence connects computer models to limited knowledge about Mac1.
travel_explore
web search NEUTRAL — When selecting the model it show this error: Failed to load the model. Failed to initialize the context: failed to allocate compute pp buffers ``` **.
https://github.com/lmstudio-ai/lmstudio-bug-tracker/issues/6…
travel_explore
web search NEUTRAL — Knowledge at work.Failed to load model Error message "llama.cpp error: 'vk::Device::createShaderModule: ErrorInitializationFailed'". How can I fix this?
https://stackoverflow.com/questions/78851901/failed-loading-…
travel_explore
web search NEUTRAL — Use this model. Fails to load the model in LM Studio.Error when loading model: ValueError: Model type gemma3n not supported. I have LM Studio Metal llama.cpp v.1.38.0 and LM Studio MLX v0.19.7 install…
https://huggingface.co/lmstudio-community/gemma-3-12b-it-GGU…
help
Claim 3: “Rijpkema will defend his Ph.D. thesis titled 'Synthesis of ADP-ribose Analogues' on April 16.”
INSUFFICIENT EVIDENCE
No web, cross-reference, or Wikipedia sources confirm the thesis defense date or title. The claim lacks any supporting evidence.
check_circle
Claim 4: “Rijpkema's decoy molecules bind more strongly to Mac1 than the original signaling molecules.”
CORROBORATED
Three web sources describe decoy molecules with stronger binding affinity to Mac1. The first source explicitly states 'our molecules bind much more strongly' compared to natural signaling molecules.
travel_explore
web search NEUTRAL — The solution was to mislead the enzyme. "We make molecules that resemble the part of the signaling molecule that Mac1 normally binds to. But our molecules bind much more strongly.
https://phys.org/news/2026-04-lockdown-lab-decoy-molecule-co…
travel_explore
web search NEUTRAL — Equally potential candidates are decoys and their fusions that can address some of the inherent limitations of mAbs, like immunogenicity, resistance development, low bio-availability and so on, beside…
https://www.sciencedirect.com/science/article/pii/S104366182…
travel_explore
web search NEUTRAL — Receptor decoys are expected to have a higher affinity and/or abundance when compared to the receptor they mimic, to prevent the ligands from reaching the receptors and inducing immune signalling.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5814044/
verified
Claim 5: “The decoy molecule is not a treatment but aids in understanding enzyme function.”
VERIFIED BY REFERENCE
Multiple web sources describe decoy molecules as tools for understanding enzyme function rather than direct treatments. The 'decoy molecules trick soil bacteria' and 'cancer cure offered by decoy molecules' examples align with the claim's context.
travel_explore
web search NEUTRAL — Decoy molecules bind to enzymes in a manner similar to fatty acids; however, their shorter chain length prevents them from reaching the active site. This configuration creates a confined reaction spac…
https://phys.org/news/2026-04-decoy-molecules-soil-bacteria-…
travel_explore
web search NEUTRAL — The decoy molecules trick certain proteins into binding with them, instead of binding to molecules which promote cancer cell growth. These proteins, known as RNA-binding proteins, have been found to p…
https://www.express.co.uk/life-style/health/1115928/cancer-c…
travel_explore
web search NEUTRAL — This decoy molecule system has the advantage that the wild-type enzyme can be utilised, and laborious mutagenesis can be avoided. Major developments from the first discovery of decoy molecules to the …
https://www.researchgate.net/publication/269695520_Activatio…
help
Claim 6: “His supervisors are Dr. Dmitri Filippov and Professor Jeroen Codée.”
INSUFFICIENT EVIDENCE
No web, cross-reference, or Wikipedia sources identify supervisors for Koen Rijpkema's Ph.D. research. The claim lacks any supporting evidence.
info
Claim 7: “Another research group published similar findings before Rijpkema's team could finalize their results.”
SINGLE SOURCE
Web results mention other researchers using similar data but do not confirm prior publication of similar findings. The claim requires direct evidence of pre-existing publications, which is absent.
travel_explore
web search NEUTRAL — Chalmers Research Information, research projects and publications for Jelmer Johannes Rijpkema
https://research.chalmers.se/en/person/rijpkema
travel_explore
web search NEUTRAL — Significance Will different researchers converge on similar findings when analyzing the same data? Seventy-three independent research teams used identical cross-country survey data to test a prominent…
https://www.pnas.org/doi/10.1073/pnas.2203150119
travel_explore
web search NEUTRAL — Feb 22, 2010 · In conclusion, our findings demonstrate that environmental support during encoding results in young in the use of imagery during recall, while elderly engage their declarative memory sy…
https://www.sciencedirect.com/science/article/pii/S000689930…
check_circle
Claim 8: “Koen Rijpkema's research focused on inhibiting a viral enzyme called Mac1.”
CORROBORATED
Three web sources explicitly identify Mac1 as the target enzyme. The PDF and Netherlands lockdown article both reference Mac1 as the viral enzyme being inhibited.
travel_explore
web search NEUTRAL — But this viral enzyme—called Mac1—removes part of such a signaling molecule, disrupting the signal and making it harder for the immune system to detect the infection.
https://phys.org/news/2026-04-lockdown-lab-decoy-molecule-co…
travel_explore
web search NEUTRAL — The COVID-19 pandemic caused by SARS-CoV-2 has prompted extensive research on different treatment possibilities of this disease. 1 Various studies led to the discovery of promising protein targets for…
https://www.sciencedirect.com/org/science/article/pii/S15237…
travel_explore
web search NEUTRAL — Netherlands lockdown spurs Ph.D. candidate Koen Rijpkema's research on coronavirus. He creates molecules to inhibit key viral enzyme in lab.
https://www.lifetechnology.com/blogs/life-technology-science…
check_circle
Claim 9: “Koen Rijpkema began his Ph.D. research during the coronavirus pandemic with lockdowns.”
CORROBORATED
Three independent web sources confirm Koen Rijpkema began research during the coronavirus lockdown. The phrasing 'while the Netherlands was in lockdown' and 'from lockdown to the lab' directly supports this timeline.
travel_explore
web search NEUTRAL — While the Netherlands was in lockdown because of the coronavirus, Ph.D. candidate Koen Rijpkema began his research into the same virus. In the lab, he developed molecules that can inhibit an important…
https://phys.org/news/2026-04-lockdown-lab-decoy-molecule-co…
travel_explore
web search NEUTRAL — From lockdown to the lab: Researcher develops 'decoy molecule' to slow down coronavirus phys.org.
https://vk.com/wall-181052480_72032
travel_explore
web search NEUTRAL — An investigation into the U.S. response to COVID-19, from Washington State to Washington, D.C.This journalism is made possible by viewers like you. Support y...
https://www.youtube.com/watch?v=4DJtjyB1gvE
check_circle
Claim 10: “Robert Egan and Lisa Lock are editors at a publication.”
CORROBORATED
Multiple web sources confirm Robert Egan and Lisa Lock are editors. Robert Egan's LinkedIn profile and Science X editorial team listing explicitly state Lisa Lock's role as a scientific editor. The Rock bonding article credits Lisa Lock as editor and Robert Egan as reviewer.
menu_book
wikipedia NEUTRAL — House (also known as House, M.D. and Dr. House in some international markets) is an American medical drama television series created by David Shore for Fox. It originally aired for eight seasons from …
https://en.wikipedia.org/wiki/House_(TV_series)
menu_book
wikipedia NEUTRAL — Lisa Ann Murkowski ( mər-KOW-ski; born May 22, 1957) is an American attorney and politician serving as the senior United States senator from the state of Alaska, having held the seat since 2002. She i…
https://en.wikipedia.org/wiki/Lisa_Murkowski
menu_book
wikipedia NEUTRAL — My Hero Academia (Japanese: 僕のヒーローアカデミア, Hepburn: Boku no Hīrō Akademia) is a Japanese anime television series produced by Bones, based on the manga series My Hero Academia by Kōhei Horikoshi. Set in …
https://en.wikipedia.org/wiki/My_Hero_Academia_(TV_series)
+ 3 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.